Our customer, emyria, has been awarded by the Western Australia Future Health Research and Innovation Fund with a digital health monitoring grant.
Emyria’s unique digital health technology and clinical team will be playing a significant role in monitoring the clinical and mental wellbeing of vulnerable populations in Western Australia including COVID19, Respiratory and Mental Health Patients.
Leveraging the Happitech module, Emyria’s platform Openly will collect remotely from individuals real-world clinical data such as heart rate and heart rate variability. Any change of the vital signs from baseline can indicate early infection or mental distress. This information, once presented to the clinical team, can be acted on more timely and accurately.
“It’s very pleasing to see our unique contactless remote monitoring platform – Openly – recognised through this competitive grant process. Emyria’s unique digital health technology and clinical team will be playing a major role in improving how we monitor the clinical and mental wellbeing of vulnerable populations in WA.
Emyria has been developing digital health and remote monitoring technologies to improve the care of patients with unmet needs. We focus on the care of complex patients and those with mental health concerns.
Openly – the core technology of this grant – will also support and monitor patients during our upcoming clinical trials. These pivotal studies will support the registration of our leading drug candidate EMD-003 – targeting unmet needs in psychological distress and the symptoms of anxiety, depression and stress.”
Dr Michael Winlo, Emyria’s Managing Director.
| Technical possibilities
